• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-30a通过靶向沉默调节蛋白1抑制肺癌进展。

miR-30a suppresses lung cancer progression by targeting SIRT1.

作者信息

Guan Yaowu, Rao Zhongming, Chen Cheng

机构信息

Department of Thoracic Surgery, Zhumadian Central Hospital, Zhumadian, Henan 463000, China.

Department of Radiotherapy, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, Jiangsu 210009, China.

出版信息

Oncotarget. 2017 Dec 21;9(4):4924-4934. doi: 10.18632/oncotarget.23529. eCollection 2018 Jan 12.

DOI:10.18632/oncotarget.23529
PMID:29435152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5797023/
Abstract

The class III histone deacetylase silent information regulator 1 (SIRT1) is frequently overexpressed in a variety of tumors, including lung cancer; however, its regulatory mechanisms are largely unknown. In this study, we found that an inconsistent trend between SIRT1 protein and mRNA levels in human lung cancer tissues, suggesting that a post-transcriptional mechanism may involved in SIRT1 regulation. Because microRNAs are important post-transcriptional regulators of gene expression, candidate miRNAs that could potentially bind SIRT1 were gained through bioinformatics analyses. We further experimentally validated SIRT1 as the direct target of miR-30a by evaluating SIRT1 expression in lung cancer cells after the overexpression or knockdown of miR-30a and by luciferase assay. Moreover, we showed that miR-30a inhibited proliferation, invasion and promoted apoptosis of lung cancer cells by inhibiting SIRT1 and . Taken together, this study identified a new regulatory axis in which miR-30a and SIRT1 regulate the proliferation, invasion and apoptosis of lung cancer cells and lung tumorigenesis.

摘要

Ⅲ类组蛋白去乙酰化酶沉默信息调节因子1(SIRT1)在包括肺癌在内的多种肿瘤中经常过度表达;然而,其调控机制在很大程度上尚不清楚。在本研究中,我们发现人肺癌组织中SIRT1蛋白水平与mRNA水平之间存在不一致的趋势,这表明转录后机制可能参与SIRT1的调控。由于微小RNA是基因表达的重要转录后调节因子,通过生物信息学分析获得了可能潜在结合SIRT1的候选微小RNA。我们通过评估miR-30a过表达或敲低后肺癌细胞中SIRT1的表达以及荧光素酶测定,进一步通过实验验证了SIRT1是miR-30a的直接靶点。此外,我们表明miR-30a通过抑制SIRT1抑制肺癌细胞的增殖、侵袭并促进其凋亡。综上所述,本研究确定了一个新的调控轴,其中miR-30a和SIRT1调节肺癌细胞的增殖、侵袭和凋亡以及肺肿瘤发生。

相似文献

1
miR-30a suppresses lung cancer progression by targeting SIRT1.微小RNA-30a通过靶向沉默调节蛋白1抑制肺癌进展。
Oncotarget. 2017 Dec 21;9(4):4924-4934. doi: 10.18632/oncotarget.23529. eCollection 2018 Jan 12.
2
miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.微小RNA-543通过靶向沉默调节蛋白1促进胃癌细胞增殖。
Biochem Biophys Res Commun. 2016 Jan 1;469(1):15-21. doi: 10.1016/j.bbrc.2015.11.062. Epub 2015 Nov 22.
3
miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.miR-30a 通过靶向 Eya2 抑制乳腺癌细胞增殖和迁移。
Biochem Biophys Res Commun. 2014 Mar 7;445(2):314-9. doi: 10.1016/j.bbrc.2014.01.174. Epub 2014 Feb 4.
4
MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.微小RNA-133b通过靶向沉默调节蛋白1抑制肝癌细胞进展。
Exp Cell Res. 2016 May 1;343(2):135-147. doi: 10.1016/j.yexcr.2016.03.027. Epub 2016 Apr 19.
5
Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.微小RNA 30a靶向胰岛素受体底物2在结直肠癌发生中的作用
Mol Cell Biol. 2015 Mar;35(6):988-1000. doi: 10.1128/MCB.01242-14. Epub 2015 Jan 12.
6
MiR-30a-5p accelerates adipogenesis by negatively regulating Sirtuin 1.微小RNA-30a-5p通过负向调控沉默调节蛋白1来加速脂肪生成。
Int J Clin Exp Pathol. 2018 Nov 1;11(11):5203-5212. eCollection 2018.
7
MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.微小RNA-30a通过靶向Myb相关蛋白B抑制非小细胞肺癌。
Exp Ther Med. 2018 Feb;15(2):1633-1639. doi: 10.3892/etm.2017.5559. Epub 2017 Nov 24.
8
miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.微小RNA-378通过抑制SDAD1抑制结肠癌细胞的增殖、迁移和侵袭。
Cell Mol Biol Lett. 2017 Jul 17;22:12. doi: 10.1186/s11658-017-0041-5. eCollection 2017.
9
Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.miR-494 的异位表达通过调节 SIRT1 和 c-Myc 抑制了胰腺癌的增殖、侵袭和化疗耐药性。
Gene Ther. 2015 Sep;22(9):729-38. doi: 10.1038/gt.2015.39. Epub 2015 Apr 28.
10
Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.缺氧诱导的微小RNA-224通过直接靶向胃癌中的RASSF8促进细胞生长、迁移和侵袭。
Mol Cancer. 2017 Feb 7;16(1):35. doi: 10.1186/s12943-017-0603-1.

引用本文的文献

1
Understanding the multifaceted role of miRNAs in Alzheimer's disease pathology.理解 miRNA 在阿尔茨海默病病理中的多方面作用。
Metab Brain Dis. 2024 Jan;39(1):217-237. doi: 10.1007/s11011-023-01265-9. Epub 2023 Jul 28.
2
Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas.磷酸化核 DICER1 促进肺腺癌中 AT2 肿瘤细胞的开放染色质状态和谱系可塑性。
Sci Adv. 2023 Jul 28;9(30):eadf6210. doi: 10.1126/sciadv.adf6210. Epub 2023 Jul 26.
3
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.

本文引用的文献

1
microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer.微小RNA-494是一种潜在的预后标志物,通过靶向沉默信息调节因子1(SIRT1)抑制上皮性卵巢癌的细胞增殖、迁移和侵袭。
Oncol Lett. 2017 Sep;14(3):3177-3184. doi: 10.3892/ol.2017.6501. Epub 2017 Jun 30.
2
The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.miR-125a/HK2 轴调控肝癌细胞能量代谢重编程。
Sci Rep. 2017 Jun 8;7(1):3089. doi: 10.1038/s41598-017-03407-3.
3
MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
免疫系统和分子细胞信号通路在肺癌发病机制和进展中的重要性。
Int J Mol Sci. 2023 Jan 12;24(2):1506. doi: 10.3390/ijms24021506.
4
Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.非小细胞肺癌的细胞行为受 EGFR 和 microRNAs 调控。
Int J Mol Sci. 2021 Nov 19;22(22):12496. doi: 10.3390/ijms222212496.
5
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.基于基因共表达网络分析的冠状病毒(SARS-CoV-2)药物再利用。
Sci Rep. 2021 Nov 8;11(1):21872. doi: 10.1038/s41598-021-01410-3.
6
MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA.微小 RNA-326 通过抑制组蛋白去乙酰化酶 SIRT1 介导的 HIF1α 和上调 VEGFA 来损害非小细胞肺癌的化疗耐药性。
Bioengineered. 2022 Mar;13(3):5685-5699. doi: 10.1080/21655979.2021.1993718.
7
Increased microRNA-30a levels in bronchoalveolar lavage fluid as a diagnostic biomarker for lung cancer.支气管肺泡灌洗液中微小RNA-30a水平升高作为肺癌的诊断生物标志物
PeerJ. 2021 Jun 9;9:e11528. doi: 10.7717/peerj.11528. eCollection 2021.
8
UVA influenced the SIRT1-miR-27a-5p-SMAD2-MMP1/COL1/BCL2 axis in human skin primary fibroblasts.UVA 影响人皮肤原代成纤维细胞中的 SIRT1-miR-27a-5p-SMAD2-MMP1/COL1/BCL2 轴。
J Cell Mol Med. 2020 Sep;24(17):10027-10041. doi: 10.1111/jcmm.15610. Epub 2020 Aug 13.
9
miR-30a inhibits breast cancer progression through the Wnt/β-catenin pathway.微小RNA-30a通过Wnt/β-连环蛋白信号通路抑制乳腺癌进展。
Int J Clin Exp Pathol. 2019 Jan 1;12(1):241-250. eCollection 2019.
10
MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer.miR-421 在非小细胞肺癌中过表达并促进细胞增殖。
Med Princ Pract. 2020;29(1):80-89. doi: 10.1159/000503020. Epub 2019 Sep 2.
微小RNA-26通过抑制自噬增强肝癌细胞的化疗敏感性并促进其凋亡。
Cell Death Dis. 2017 Jan 12;8(1):e2540. doi: 10.1038/cddis.2016.461.
4
MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT).微小RNA-30a通过抑制上皮-间质转化(EMT)增加胃癌细胞对顺铂的敏感性。
Eur Rev Med Pharmacol Sci. 2016 May;20(9):1733-9.
5
MiR-30a and miR-205 are downregulated in hypoxia and modulate radiosensitivity of prostate cancer cells by inhibiting autophagy via TP53INP1.MiR-30a和miR-205在缺氧条件下表达下调,并通过TP53INP1抑制自噬来调节前列腺癌细胞的放射敏感性。
Eur Rev Med Pharmacol Sci. 2016 Apr;20(8):1501-8.
6
MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.微小RNA-30a-5p通过靶向AEG-1抑制肝癌细胞的生长并增强其凋亡。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15632-41. eCollection 2015.
7
Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.miR-30a-5p 通过下调β3 整合素调控三阴性乳腺癌细胞黏附和侵袭,阻断 Erk/Ets-1 信号通路。
Int J Oncol. 2016 Mar;48(3):1155-64. doi: 10.3892/ijo.2016.3319. Epub 2016 Jan 5.
8
Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer.非小细胞肺癌中 microRNA 的表达谱分析以及下调的 miR-486-5p 和 miR-30a-5p
Oncol Rep. 2015 Oct;34(4):1779-86. doi: 10.3892/or.2015.4141. Epub 2015 Jul 21.
9
MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.微小RNA-30a通过靶向胰岛素样生长因子1受体,经由AKT信号通路抑制非小细胞肺癌进展。
Cell Mol Biol (Noisy-le-grand). 2015 May 28;61(2):78-85.
10
miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.miR-30a 通过靶向 Eya2 抑制乳腺癌细胞增殖和迁移。
Biochem Biophys Res Commun. 2014 Mar 7;445(2):314-9. doi: 10.1016/j.bbrc.2014.01.174. Epub 2014 Feb 4.